Title: A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.
Journal: Toxicology and applied pharmacology 20150415
Title: Presynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors.
Journal: Neuroscience 20120927
Title: 3-Substituted phenylalanines as selective AMPA- and kainate receptor ligands.
Journal: Bioorganic & medicinal chemistry 20090901
Title: Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation.
Journal: British journal of pharmacology 20090601
Title: Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.
Journal: Neuroscience 20090303
Title: Subunit-dependent postsynaptic expression of kainate receptors on hippocampal interneurons in area CA1.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20090114
Title: Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLUK5 kainate receptor antagonists.
Journal: Journal of medicinal chemistry 20070405
Title: Presynaptic inhibition by kainate receptors converges mechanistically with presynaptic inhibition by adenosine and GABAB receptors.
Journal: Neuropharmacology 20061101
Title: Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies.
Journal: Journal of medicinal chemistry 20061005
Title: Structure-activity relationship studies on N3-substituted willardiine derivatives acting as AMPA or kainate receptor antagonists.
Journal: Journal of medicinal chemistry 20060420
Title: Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20060315
Title: Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.
Journal: Journal of medicinal chemistry 20051201
Title: More JC, et al. Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist. Neuropharmacology. 2004 Jul;47(1):46-64.
Title: Dolman NP, et al. Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors. J Med Chem. 2005 Dec 1;48(24):7867-81.
Title: Apland JP, et al. The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302. J Pharmacol Exp Ther. 2014 Nov;351(2):359-72.
